The PDF is freely available. It rehashes what we already know about SIRFLOX, no recommendation for early line use at this stage outside of clinical trial setting. This might all change when the OS data is available next year. please please please please please
- Forums
- ASX - By Stock
- Ann: Becoming a substantial holder-SRX.AX
The PDF is freely available. It rehashes what we already know...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
18.5¢ |
Change
0.025(15.6%) |
Mkt cap ! $78.52M |
Open | High | Low | Value | Volume |
18.0¢ | 19.0¢ | 17.5¢ | $392.2K | 2.150M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 871626 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 318889 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 424992 | 0.185 |
5 | 526984 | 0.180 |
6 | 1172727 | 0.175 |
4 | 381000 | 0.170 |
3 | 336367 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 298889 | 8 |
0.195 | 10000 | 1 |
0.200 | 324181 | 9 |
0.210 | 206478 | 4 |
0.230 | 40000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online